Affordability For Patients
Caps can lower out-of-pocket costs for people who depend on a product, like the 8.4 million Americans the CDC estimates use insulin.
In plain English
When the government limits the price.
A legal ceiling on how much sellers can charge for something. The government sets a maximum price, and companies cannot legally charge more.
Simple example
The Inflation Reduction Act of 2022 capped monthly insulin copays at $35 for Medicare Part D enrollees, taking effect in January 2023.
Why it matters
What the term actually changes.
Market Tradeoffs
Supporters say caps prevent price gouging on essentials, while critics argue they can reduce industry revenue used for research and may shift costs elsewhere in the system.
How it works
The mechanics, in practice.
Set By Law
Congress or a regulatory agency establishes a maximum price or copay through legislation or rulemaking, often targeted at specific products or buyers.
Enforcement And Scope
The cap applies to defined groups, such as Medicare beneficiaries or all insured patients, and is enforced through insurance rules, penalties, or program participation requirements.
Related guide
Should the federal government cap the price of insulin?
A look at how insulin is priced in the U.S., what Congress has already done, and the arguments on each side of a broader price cap.
Read the guide → Related issue brief
Should the federal government cap the price of insulin?
Lawmakers and analysts disagree over whether Washington should set a nationwide ceiling on what patients pay for a century-old drug used by millions of Americans.
Read the brief →You’ve learned the term. Now vote.
Should the federal government cap the price of insulin?
Live results — 137 voters
Anonymous · one vote per person